11:30pm (EST)
1. Market Summary
2. Star Scientific (STSI) – Safe Tobacco Catching On
3. Earnings
4. Weekly Wrap Portfolio Update
5. Week Ahead
(To view the charts, please log into the Members Area and go to the Weekly Wrap Premium section. We have a ton of charts to go over so please look at them to get the clues on where this market is headed.)
= = = = = = = = = = = = = = =
1. Market Summary
“We went on record in mid-August and said the market could move 5% in September and 10% by year-end up or down depending on the headlines which is why we showed you the 10-year charts again.
The targets we gave were Dow 14,000 or 12,600 in September followed by 14,500-14,600 or 12,000 by year-end. We said the S&P 500 could be at 1,500 or 1,350 next month which would lead to 1,550 or 1,275 by Thanksgiving/ Christmas. We mentioned the Nasdaq could push 3,225-3,250 or 2,925-2,900 in September and then 3,375-3,400 or 2,800-2,775 on continued strength or weakness.
Last week, the market moved 2% on the ECB news but nothing is a given until Germany gives the green light on the ECB’s “plan” of a “conditional” bond buying program. The austerity measures are stringent which may prevent Spain and other countries from applying for it right away. Of course, nothing was really accomplished but it sounded like the printing presses were getting some fresh plates which should keep the debt-yields down on Italian and Spanish bonds.
The bulls were also helped by China which announced its own “QE” package with more than a trillion, or $160 billion, infrastructure spending program. This pumped China’s stock market up by nearly 4% but they could be reporting some very disappointing economic numbers starting this week. China wanted to announce some good news before it reported the other news over the weekend and into this week.
U.S economic news is also heavy again this week but the market will be more focused on what Germany says about the European Stability Mechanism (ESM) and the EFSF. The news should be out before Wall Street opens. The Fed is hoping Germany signs off on everything because they will meet on Wednesday with a statement on Thursday.
Given the weak jobs numbers, there is a lot of pressure on Ben Bernanke to do something but if Germany doesn’t approve Draghi’s new plan, Big Ben could stall as he is not willing to show his hand first but might have to.
The jobs numbers from last week may have handcuffed the Fed or been a blessing as QE3 is still going to come sooner rather than later. It is on Bernanke on when he wants to make it official and the market won’t know for sure how things will play out until week’s end.
We have said any negativity this week could cause a pullback and longer-term selloff but we wouldn’t be surprised if there was only a slight pullback to support and then a strong year-end Romney rally. It will just depend on how things play out this week and for the rest of the month.
The U.S. debt ceiling will again be in focus over the next few weeks and earnings season will start back in October. This means between now and the rest of the month, we could see more warnings as there have already been some high-profile names lowering guidance.
The charts are showing one last possible push to new highs and we will continue to try to play the momentum higher but we aren’t ready to go all-in. At some point, the technical picture should take over instead of geopolitical news and events which will favor the bears. In the meantime, the bulls are doing their best Pink Floyd by adding bricks to the wall of worry.” (from 9/9/2012 Weekly Wrap/ Monday Morning Outlook)…
The market made another strong push last week as the major indexes hit multi-year highs following the “good news” from the Fed and Germany. All of last week’s major events went perfectly for the bulls after China got the ball rolling before Monday’s open followed by Germany signing-off on the ESM on Wednesday. The big bat grand-slam swing came on Thursday from Fed Chairman, Ben Bernanke, whom many doubted would bring out the bazooka. Wrong. The Bernanke knew there was no bluffing this time as he waited for the rest of the world to commit first and, figuring he had the best hand, he is putting the U.S. all-in. The call is $40 billion a month but this pot is going to get bigger and Big Ben has $40 billion more (a month) he can play poker with. One thing is for sure. The market is going to get very volatile from here on out.
The Dow gained 53 points, or 0.4%, to finish at 13,593 on Friday. The blue-chips traded to a low of 13,251 on Monday and 13,253 on Tuesday which was above support at 13,200-13,250. This gave us an inkling the bulls would make a run to our next target of 13,350. Wednesday’s close on the positive Germany vote was 13,333 with the high being 13,373. If you split it in the middle you get 13,353. This was our clue Big Ben was going to come through and we said the next wave of resistance would be at 13,500-13,600 with fluff up to 14,000. Thursday’s high was 13,573 and Friday’s high was 13,653. The first wave of support is now at 13,350 then 13,200. The Dow started Monday at 13,306 and gained 287 points, or 2.2%, for the week. For the year, the blue-chips are up 1,376 points, or 11.3%. In the past 2 weeks, the blue chips are up 503 points. Below is a 15-year monthly chart for the Dow:
Here is last week’s chart for the Dow:
The S&P 500 added 6 points, or 0.4%, to end at 1,465. The index traded to a low of 1,428.98 on Monday and 1,429.13 on Tuesday which was above support at 1,425. Our next target was 1,450 and Wednesday’s high was 1,439. Thursday’s surge to 1,463 was confirmation our 1,500 target could be triggered and Friday’s high was 1,474.51. We would have liked to have seen 1,475 cleared on the close which is now Monday’s task. The bears will target a close below 1,450 and then 1,425 to try to slow the momentum this week. The S&P 500 came into the week at 1,437 and was up 28 points, or 1.9%, after Friday’s closing bell. For 2012, the index is showing a gain of 208 points, or 16.6%. For the month, the S&P is up 59 points.
The S&P 500 chart from last week:
The Nasdaq advanced 28 points, or 0.9%, to settle at 3183.95. Tech tested a low of 3,102 on Monday and 3,099.10 on Tuesday which was right at support of 3,100. Wednesday’s low was 3,098.82 but the Nasdaq reached 3,120 heading into the Fed announcement. We wanted to see 3,125 trip before the news which was our sign 3,150 would be cleared and it seemed close enough. We said a move to 3,225-3,250 was possible if this level was cleared and on Thursday the index closed at 3,155. Friday’s high was 3,195. Support is prior resistance which means a move back below 3,000 could be a bearish warning or trend change. The Nasdaq started Monday at 3,136 and jumped 47 points, or 1.5%, for the 5 trading days. YTD, the index is zooming 578 points, or 22.2%. In 2 weeks, Tech is up 117 points.
Here is the chart for the Nasdaq from last week:
The Russell 2000 was higher by 8.58 points, or 1%, on Friday and closed at 864.70. The small-caps traded in a tight range to begin the week and only fell 3 points on its close of 839 on Monday while adding 2 points to 842 on Tuesday’s close. Wednesday’s close of 845 was just under our 850 target heading into the Fed meetings. No worries. The bulls cleared the level on Thursday’s pop to 860. This opened the door for a run to our next targets of 875-900 for the index. Support has now moved up to 850 with 830 serving backup. The Russell 2000 began the week at 842 and was up 22 points, or 2.7%, following Friday’s close. For 2012, the index is showing a gain of 124 points, or 16.7%. For September, the small-caps are up 52 points.
Here is the chart for the Russell 2000 from last week:
The S&P Volatility Index ($VIX, 14.51, up 0.46) came into the week at 14.38 and jumped 13% on Monday to close 16.28. The move back above 15 made some of the suit-and-ties nervous but the bears could not muster a push past 16.54 which was the high before Bernanke spoke. Resistance is at 17.50 and but is moving lower (16.50) as the VIX heads towards the low teens. The VIX stayed in the low teens for 2 years (2005-2007) and traded to single-digits so the Wall Street pros need to remember this before telling you we are flirting with danger at 15…but they won’t.
Here is VIX chart from last week:
Gold and Silver put in another strong week following the Fed’s QE3 announcement which stocked fears of inflation.
Gold was up $35 on Friday and closed at $1,773.50 an ounce. We mentioned in July Gold could run to $1,800 and in late August we reiterated that prediction. Last week we upped our target to $2,000 for 2012.
Gold chart from late August:
Silver closed at $34.74 on Friday, up $1.06. We said in July to add to your Silver positions at $26 by buying American Eagles and reiterated those feelings on the move above $30. The next level of resistance is at $36 and with last week’s move a run to $40 is quite possible over the near-term.
Here is our Silver chart from late August”
The Financial Select Sector ETF (XLF, $16.28, up $0.13) continues to show strength and we said back in July a move above $15 would be bullish. This occurred at the end of August. Near-term resistance is at $18.
Our chart work from July for the XLF:
The market has moved 4% for the month of September and we will need another 2%-3% over the next 2 weeks to reach our fluff targets of Dow 14,000; S&P 1,500; Nasdaq 3,250; and 900 for Russell 2000.
Monday’s have been dominated by the bears over the past 3 months and a win by the bulls would be a good sign to start the week. The Dow will get a new component on Monday as Kraft Foods (KFT, $39.93, down $0.20) is out and Unitedhealth Group (UNH, $54.25, up $0.36) is in. This could help the index as traders prop up the stock.
Kraft will be splitting into two companies. Kraft Foods which will focus growing the grocery business and will trade on the Nasdaq under the ticker symbol “KFRT” starting next Monday. The parent company will be called Mondelez International and will also trade on the Nasdaq under the ticker symbol “MDLZ”.
FedEx (FDX, $90.15, down $0.21) will report earnings on Tuesday and they warned Wall Street a few weeks ago they were going to miss estimates. This could be bullish for the stock as they have lowered expectations already. The Dow Transports have been in rally mode and we told you this was a key index to watch coming into September to confirm the Dow and blue-chips had legs.
Here is how the Transports look after Friday’s close:
The rest of the week is filled with a few high-profile earnings from companies with different fiscal year endings, but official 3Q earnings season won’t start until the second week of October.
Between now and the beginning of October, companies usually warn and with FedEx and Intel (INTC, $23.37, up $0.02) giving Wall Street a heads-up, others will follow. AK Steel Holding (AKS, $5.87, down $0.57) tried to sneak theirs in on Friday after saying they expect higher losses for the quarter. That didn’t work as shares tanked 9%.
Economic news will be dominated by Housing numbers and they should come in better-than-expected although it’s not a given. The big report should be the Philly Fed on Thursday.
This week is option expiration week for the September chains and it can be bullish, especially on Fridays. The Dow has been up on the past seven September Triple Witching Friday’s and 8-out-of-9. Triple Witching is when all option and index futures expire and it happens 4 times a year – March, June, September and December. The talking heads will throw caution the event but again, it is usually a bullish day for September TW.
Apple (AAPL, $691.28, up $8.30) certainly helped the bulls by surging to new all-times highs. Shares reached a peak of $696.98 on Friday and here was our thoughts midweek on the stock and before the official launch of the iPhone5.
“Apple (AAPL, $660.39, down $0.20) is expected to announce the iPhone5 today and there are a ton of analysts saying shares have a history of selling off after a product announcement. While this is true, this time could be different as Apple will sell a ton of these phones. There are also rumors of an iPad mini which would also be big news.” (END)
Shares of Apple were up $30 afterwards and $10 for the week. If shares do selloff from here or pullback, you can bet there will be a knucklehead that says, we told you so. Well, if they do, we will have to remind of them of the $40 point pop AFTER the announcement.
Apple won another key legal verdict last week that will allow them to file for an injunction against Google’s Motorola devices. This follows a huge legal victory against Samsung and gives Apple leverage going forward. As far as the iPad mini, we think it could now come in October which could get shares to $750-$800 on continued momentum.
With Europe and the Fed yesterday’s news, the market should continue higher this week and into month end as some mutual and hedge fund managers will surely be chasing. Many of them have sat out the rally following their August vacations and we told you they could be forced to buy as they also discounted The Bernanke whom they thought would disappoint the market. It’s a good thing poker is our second favorite profession besides trading options.
As we head to press, futures are showing a slightly lower open for Monday but it is early. Dow futures are down 23 points to 13,495 while the S&P 500 futures are lower by 2 points to 1,456. The Nasdaq 100 futures are off by 3 points to 2,847.
= = = = = = = = = = = = = = =
Key of Technicals Used In Following Articles
2. Star Scientific (STSI) – Safe Tobacco Catching On
By Michael Bryant
Star Scientific’s (STSI, $3.63, up $0.01) stock has been oscillating for much of this year. Now, as the stock is at a short-term low and benefits from its line of products start to appear, is this a good time to buy?
The Star Tobacco division sells very low-TSNA dissolvable smokeless tobacco products. Its four products are Ariva®, STONEWALL Hard Snuff®, Ariva BDL™, and Stonewall BDL™. Ariva® is compressed powdered StarCured® tobacco pieces that dissolve completely in the smoker’s mouth. Stonewall Hard Snuff® is designed to be an alternative for adult users of traditional smokeless products like moist snuff and chewing tobacco. Like Ariva®, Stonewall Hard Snuff® is made with StarCured® tobacco and dissolves completely in the mouth. It also appears to be very helpful to smokers who use more than 1.5 packs of cigarettes per day. Both Ariva BDL™ and Stonewall BDL™ have TSNA levels that were below detection limits in independent standard test measures. These two products currently are not subject to regulation under the Tobacco Control Act, which imposes new warnings and labels on tobacco packaging and their advertisements, bans flavored cigarettes, places limits on the advertising of tobacco products to minors, and requires tobacco companies to seek FDA approval for new tobacco products.
The Rock Creek Pharmaceuticals division has been focusing on utilizing certain alkaloids found in the Solanacea family of plants, which includes potatoes, tomatoes, eggplants, and tobacco. The company has been concentrating on the apparent ability of one of those alkaloids, anatabine, to promote a healthy inflammatory balance when taken as a dietary supplement, thus paving the way for Anatabloc®, for anti-inflammatory support, and CigRx®, for assistance in fighting the urge to smoke cigarettes. The division also develops dietary supplements and pharmaceutical products that have a botanical-based component to treat a range of neurological conditions, including Alzheimer’s disease, Parkinson’s disease, schizophrenia, and depression.
One very enthusiastic customer notes how Anatabloc® has changed his life. He describes that he used to have inflammation after playing golf, but after taking the tablet, he no longer has inflammation after playing golf. He goes on further that he has no more pain in his knees, can sleep better, has better eyesight, has sharper memory, has fewer wrinkles, and has a lower tendency to snack (thus losing 25 pounds). Thus, the tablets could be used to treat many situations.
Fred Couples, winner of the 2012 Senior British Open, and other athletes are also using the product. Couples’ win marked the first individual victory in Britain for the 52-year-old veteran of the PGA Tour, and his 2nd win of 2012. According to him, within days after using it to manage excessive inflammation, he started feeling better. In February 2012, he became Brand Ambassador for Anatabloc® and now wears the Anatabloc® logo on his sleeve during competition.
Studies have also shown Anatabloc® works on dogs with arthritis and allergies, as well as mice that have lost functions in their legs. After taking the supplement, the mice regained movement in their legs. This implies that it can be use for veterinary medicine and a probable treatment for multiple sclerosis.
Sales could also be boosted by upcoming raises in the state tobacco tax. Both Missouri and Nebraska are considering raising the tax. This may be a win for CigRx®.
On August 23rd, the company enrolled its first patient for the Alzheimer’s study of its dietary supplement Anatabloc®. The supplement has been reported to be a useful nutritional supplement in Alzheimer’s disease. The company received a patent for the synthesis of anatabine in June 2012, and a patent is pending for the Anatabloc® formulation.
The stock fell after it reported 2nd quarter earnings on August 9th. Its next earnings report is not until November 9th. Analysts expect 3rd quarter earnings of -$0.03 per share but they expect next year’s earnings to be $1 a share.
Revenue has been increasing, but total expenses seem to be increasing at a faster pace. This could spell trouble for the company. Revenues from tobacco products have been flat. If this division can grow as mentioned above, then revenue could start to take off. Dietary supplements currently make the bulk of total revenue, and this trend would likely remain the same for some time as dietary supplement growth far outpaces growth in tobacco products. Analysts’ earnings estimates show they believe the company will show a sharp rise in year-over-year earnings in the 4th quarter.
Shares have underperformed the S&P 500 and the S&P Tobacco Group over the past 6 years. Taking a cumulative total return based on investing $100 in the company on December 31, 2006 would yield $82. Investing $100 in the S&P 500 and the S&P Tobacco Group at the same time with dividends reinvested would yield $113 and $254 respectively. Using this metric, it seems the stock is undervalued.
Due to its low forward PE, great prospects, and large cash pile, it is also possible that a large tobacco or pharmaceutical company could make a bid for the company.
Only one analyst follows the stock, placing a strong buy on it. However, no analyst has placed a price target.
|
|
Current Month |
Last Month |
Two Months Ago |
Three Months Ago |
|
Strong Buy |
1 |
1 |
0 |
0 |
|
Buy |
0 |
0 |
0 |
0 |
|
Hold |
0 |
0 |
0 |
0 |
|
Underperform |
0 |
0 |
0 |
0 |
|
Sell |
0 |
0 |
0 |
0 |
= = = = = = = = = = = = = = =
3. Earnings
The companies in BOLD, we are looking at as possible trades and we may list call or put options on them in our Daily Newsletter. If they become official recommendations, we sent out Trade Alerts or include them in our 9am and 1pm updates that come out during the week (Quotes are from 9/14/12 close)
By Catherine Tierney
Monday
Carnival (CCL, $37.96, up $0.14), China Natural Resources (CHNR, $7.00, down $0.10), HB Fuller (FUL, $33.95, up $0.31), Home Loan Servicing (HLSS, $15.79, down $0.01), Marine Petroleum Trust (MARPS, $21.40, down $0.45), Southern Missouri Bancorp (SMBC, $24.02, up $0.77), Sycamore Networks (SCMR, $15.21, up $0.31), Value Line (VALU, $9.69, down $0.17), WVS Financial (WVFC, $8.52, down $0.18)
Tuesday
ChinaEdu (CEDU, $5.85, up $0.01), Daxor (DXR, $8.74, down $0.06), FedEx (FDX, $90.15, down $0.21), Schiff Nutrition (SHF, $20.57, up $0.15)
Wednesday
AAR (AIR, $17.08, Flat), Adobe Systems (ADBE, $33.34, up $0.53), Apogee Enterprises (APOG, $17.70, up $0.17), Ascena Retail (ASNA, $21.38, up $0.46), AutoZone (AZO, $351.99, down $19.97), Bed Bath & Beyond (BBBY, $71.60, up $1.30), CLARCOR (CLC, $49.78, up $0.36), Copart (CPRT, $27.75, down $0.15), Cracker Barrel Old Country Store (CBRL, $64.13, down $2.04), General Mills (GIS, $38.89, down $0.57), Herman Miller (MLHR, $21.73, up $0.37), S&W Seed (SANW, $6.18, up $0.16), Steelcase (SCS, $10.50, up $0.30)
Thursday
CarMax (KMX, $32.34, down $1.00), Cintas (CTAS, $41.72, down $0.50), ConAgra Foods (CAG, $25.59, down $0.37), Gladstone Capital (GLADP, $25.50, up $0.11), IHS (HIS, $116.16, down $1.54), Jefferies Group (JEF, $16.03, up $0.17), Oracle (ORCL, $32.95, up $0.33), Scholastic (SCHL, $33.70, up $0.14), Marcus (MCS, $12.09, down $0.45), TIBCO Software (TIBX, $31.43, up $0.41)
Friday
Darden Restaurants (DRI, $54.04, down $0.79), InterGroup (INTG, $23.61, down $0.08), KB Home (KBH, $13.65, up $0.74), Natural Alternatives (NAII, $6.20, up $0.01)
= = = = = = = = = = = = =
4. Weekly Wrap Covered Call Portfolio Update (Closing prices as of 9/14/12)
Closed Trades for 2012 (24-0, overall): ARNA +117%, SZYM +11%, BAC +26%, EFTC +8%, SZYM +55%, VVUS +38%, CALL +19%, BAC +20%, SYMC +16%, DAR +20%,TIVO +5%, MGM +22%, ZNGA+13%, SGMS +6%, VVUS +17%, F +8%, AA +7%, CLNE +27%, DNDN +18%, MGM +19%, ACAS +3%, P +9%, BAC +6%, AA +3%.
Solazyme (SZYM, $11.33, up $0.05)
September 12.50 calls (SZYM120922C00012500, $0.10, flat)
Original Entry Price: $12.35 (8/9/12)
Lowered Price from Selling Options: $11.55
Exit Target: $15+
Return: -2%
Stop Target: $9
Action: Shares traded to a high of $11.74 on Friday. Resistance is at $12 and the 100-day MA while support has been holding up at $11.25. A break below this level would get $10.75 in play.
We recommended buying the stock at $12.35 on 8/9/2012 and for every 100 shares to sell the September 12.50 calls for 80 cents. This lowered the cost basis to $21.75.
If we are called away in mid-September at $12.50 the trade will make 8%.
Vivus (VVUS, $22.08, down $0.31)
September 24 calls (VVUS120922C00024000, $0.30, down $0.10)
Original Entry Price: $22.70 (7/27/12)
Lowered Price from Selling Options: $21.35
Exit Target: $30+
Return: 3%
Stop Target: $15
Action: Shares are setting up for a big move and a break above resistance at $23 would be bullish to a trip to $24+. A dip below $21 and then $20 would be bearish.
We recommended buying the stock at $22.70 on 7/27/2012 and for every 100 shares to sell the August 24 calls for 95 cents. This lowered the cost basis to $21.75.
On 9/6/12 we sold the September 24 calls for 40 cents which lowered our cost basis to $21.35. If we are called away at $24 in a couple of weeks, the trade will make 12%.
Antares Pharma (ATRS, $3.96, up $0.02)
November 5 calls (ATRS121117C00005000, $0.30, up $0.05)
Original Entry Price: $4.94 (7/13/12)
Lowered Price from Selling Options: $3.94
Exit Target: $8+
Return: 1%
Stop Target: None
Action: The tight trading range continues between $3.80 and $4. Resistance is at $4.10 and support at $3.60 if there is a move outside of the range.
We recommended buying the stock at $4.94 on 7/13/2012 and for every 100 shares to sell the August 5 calls for 70 cents. This lowered the cost basis to $4.24.
On 9/6/12 we sold the November 5 calls for 30 cents which lowered our cost basis to $3.94. If we are called away at $5 in mid-November the trade will make 27%. .
Antares Pharma (ATRS, $3.96, up $0.02)
February (2013) 7.50 calls (ATRS130216C0007500, $0.35, flat)
Original Entry Price: $0.80 (7/13/12)
Exit Target: $1.60
Return: -56%
Stop Target: None
Action: This is a LEAP call option which has nearly 6 months before expiration. We have a target of $8-$10 for the stock which is a strong takeover candidate.
Pizza Inn (PZZI, $3.37, down $0.07)
Original Entry Price: $4.50 (2/22/12)
Lowered Price from Selling Options: No options listed (yet)
Exit Target: $9
Return: -25%
Stop Target: None
Action: Shares traded in a tight 14 cent range all week. Short-term support is at $3.35 then $3.20. A break above resistance at $3.50 would be bullish and get $4 back in play.
Pizza Inn continues to open new pie shops in Texas. The company’s latest restaurant on the University of Texas campus was its seventh location with an eighth planned in Allen, Texas.
The company recently won the prestigious 2012 Hot Concepts award from the Nation’s Restaurant News and the buzz is growing. The company is targeting 75 major cities to expand and some will be company owned or franchised. Insiders are buying shares at these low levels and we feel you should be loading up too while they are still under $4. We have a 12 to 18-month price target of $10 for Pizza Inn.
MGM Resorts (MGM, $11.41, up $0.13)
Original Entry Price: $13.77 (2/2/12)
Lowered Price from Selling Options: $12.67
Exit Target: $15
Return: -10%
Stop Target: None
Action: We were looking for a close above $11.50 on Friday and came close after shares made a run at the 200-day MA ($11.72). If MGM can clear this level then we could see a run up to $13.50. Friday’s high was $11.78 and we are close to writing another option to lower our cost. Support is at $11 and then $10.75.
We recommended buying the stock at $13.77 on 2/2/2012 and for every 100 shares to sell the March 15 calls for 45 cents. This lowered the cost basis to $13.32.
On 3/20/12 we recommended selling the April 14 calls for $0.65 which lowered the cost basis to $12.67.
Newpark Resources (NR, $8.19, up $0.37)
Original Entry Price: $9.45 (7/27/11)
Lowered Price from Selling Options: $7.85
Exit Target: $11
Return: -1%
Stop Target: None
Action: Newpark broke through $8 with Friday’s 5% pop and continued its surge after gaining 13% the prior week. Shares appear ready to challenge $10 on a move above $8.50. Short-term support is moving up and is now at $7.50. The October 10 calls are going for 25 cents but the option chains only trade in 2.50 increments and the bid/ask is wide. The December 10 calls are going for 40 cents. We would rather wait for the move above $10 and sell an option then.
We recommended buying the stock at $9.45 on 7/27/2011 and for every 100 shares to sell the August 10 calls for 50 cents. This lowered the cost basis to $8.95.
On 9/15/2011 we recommended selling the December 10 calls for $0.85 which lowered the cost basis to $8.10.
On 1/25/2012 we recommended selling the March 12.50 calls for $0.25 which lowered the cost basis to $7.85.
Trades on HOLD: DryShips (DRYS, $2.59, up $0.09), AKS Steel Holding (AKS, $5.87, down $0.57), Rare Element Resources (REE, $4.93, up $0.25), Rambus (RMBS, $5.07, up $0.17), Patriot Coal (PCXCQ, $0.14, down $0.01), OCZ Technology Group (OCZ, $4.55, down $0.07), Bebe Stores (BEBE, $5.17, down $0.03), Scientific Games (SGMS, $8.37, up $0.10)
= = = = = = = = = = = = = = =
5. Week Ahead
This week’s economic news will start off with Monday’s Empire Manufacturing numbers at 8:30am (EST). This is usually a widely followed report and estimates are for a reading of -3 versus a -5.9 print in August. If the number comes in better-than-expected the market should see an up day for a change.
Tuesday’s action starts with the Current Account Balance report at 8:30am followed by Net Long-Term TIC Flows at 9am. At 10am, the NAHB Housing Market Index will be released.
On Wednesday, the MBA Mortgage Index is due out at 7am with Housing Starts and Building Permits expected at 8:30am. At 10am, Existing Home Sales will be announced followed by Crude Inventories 30 minutes later.
Initial and Continuing Claims will hit the Street at 8:30an on Thursday and the Philadelphia Fed figures will be out at 10am along with Leading Indicators.
There are no economic reports scheduled for Friday but it triple-witching day as option contracts expire.






























